Earlier this year, we examined the results of Food Engineering’s State of Food Manufacturing Survey from 2014 to 2018. It will probably come as no surprise that automation was the top trend in each of the five years. Facing the need to expand production while dealing with a dwindling workforce, processors have been scrambling to […]
Category Archives: Blog
When to Use an Infinity Vs a Bi-Flo Accumulation System
If you’re considering adding accumulation to your production lines, congratulations! You’ve taken the first step toward maximizing your throughput. Now, the big question is…”What type of accumulation?” At Garvey, we offer two main lines of accumulation systems, our InfinityTM accumulation tables and our Bi-FloTM accumulation tables. Both of these lines will increase your productivity by […]
You’re Not Supposed to Walk on It, But…
In our several decades of visiting manufacturing plants, one thing we’ve learned is that the way equipment is used in the real world can be much different from what we expect when we’re designing it. Call it “off-label use.” For example, has an operator or maintenance worker in your plant ever walked on one of […]
Workplace Stress in Manufacturing: What’s Accumulation Got To Do With It?
On this blog, and in our interactions with prospects and customers, we typically focus on how our equipment helps manufacturers increase their throughput. This shouldn’t come as a surprise — as makers of accumulation tables, throughput is our bread and butter. But, recently, we learned that lower-than-desired throughput isn’t the only challenge our accumulation systems […]
Garvey Bi-Flo Accumulation Tables Keep Production Lines Running with No Jamming, No Dead Plate, and Easy Changeover
Nearly four decades after inventing the Bi-Flo, Garvey continues to reduce manufacturing downtime with industry-leading accumulation equipment BLUE ANCHOR, N.J. (PRWEB) SEPTEMBER 17, 2019 Faced with growing margin pressure, nutraceutical, pharmaceutical, and food and beverage manufacturers are all striving toward a common goal: keeping their lines running. Consultants estimate that factories lose between 5% and 20% […]
7 Downtime Statistics That You Should Find Terrifying
In manufacturing, downtime is a four-letter word, while unplanned downtime is an unforgivable curse. You know it’s bad, but do you know how bad? These 7 statistics illustrate just how much of an impact downtime can have on your business: In 2016, the average cost of downtime across all businesses was $260,000 per hour. That […]
Is Waiting Killing Your Throughput…and Your Bottom Line?
When you think about your production lines, do you have a vague sense that you could be producing more / better / faster, but aren’t sure exactly what’s standing in your way? This is common. We talk to many plant managers who know they should be getting more out of their lines, but aren’t sure […]
Transferring Products Across a Gap? Why the Simplest Solution Is the Best
You’ve heard this story before: During the space race of the 1960s, NASA realized that regular pens, which rely on gravity, don’t work in space. So, the agency spent millions of dollars to develop a pressurized pen that astronauts could use in low-gravity environments. The Russians used a pencil. It isn’t true — NASA astronauts […]
Why Vaccine Makers Need to Improve Their Part of the Cold Chain
The vaccine cold chain is a complex system with many moving parts and multiple levels of accountability, including manufacturers, distributors, and providers. Every link in this chain is vulnerable to improper temperatures, which can render vaccines ineffective. Most of the information about the cold chain and how to improve it focuses on what happens after […]
Eliminating the Risk of Glass Particulate Contamination on High-Speed Pharma Processing Lines
No one in the pharma industry wants a recall. Not only are they expensive and potentially reputation-damaging, but they mean that patients may have been put at risk. Foreign matter contamination is a leading cause of recalls for injectables. In fact, the presence of visible particles accounted for 22% of FDA recalls of sterile injectable […]